| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |